低分子量肝素钠治疗进展型脑梗塞的临床疗效分析

An effective analysis of treating progressive cerebral infarction with low molecular weight heparin sodium

目的:探讨采用低分子量肝素钠治疗进展型脑梗塞患者的临床效果。方法:选取76例进展型脑梗塞患者的临床资料,根据治疗方法将其分为试验组(低分子量肝素钠治疗)与对照组(常规治疗),各38例。结果:治疗后,试验组的神经功能缺损改善情况明显优于对照组,差异有统计学意义(P<0.05);试验组的治疗总有效率为86.85%,显著高于对照组的68.42%,差异有统计学意义(P<0.05)。结论:对进展性脑梗塞患者采用低分子量肝素钠治疗,能有效改善患者的临床症状,疗效显著,有利于提高患者的生活质量,值得推广。

Objective： To investigate clinical effects of low molecular weight heparin sodium on progressive cerebral infarction. Methods： 76 patients with progressive cerebral infarction were selected and divided into the test group（received low molecular weight heparin sodium） and the control group（received conventional treatment）, 38 cases for each. Results： After the treatment, neurological deficit in the test group was improved, better than that in the control group. The difference was statistically significant（P〈0.05）. The total efficiency in the test group was 86.85%, much higher than that in the control group（68.42%）. Conclusion： The low molecular weight heparin sodium was significantly effective on progressive cerebral infarction, could improve the quality of life of patients, and was worthy of promotion.